[MINI-PODCAST] Ep 63: Advanced Practitioners’ Role in Research

Find the CANCER BUZZ podcast on Apple Podcasts, Spotify, Amazon Music, or wherever you get your podcasts!

In this episode, we'll explore how oncology advanced practitioners (APs) can play a greater role in clinical research and, according to a recent national study, have a strong interest in doing so. Hear how APs can leverage their deep role in the day-to-day cancer care decisions to improve diversity in clinical trials by bringing their experience to trial design and the accrual process.

 

“We deal with the side effects of treatment. We know how to identify... and manage adverse events. So in the realm of clinical research, it just makes a ton sense for us to be managing patients on trial.”

This mini-podcast—and two additional shows—will share key themes from the Summit. Look for more findings coming soon to the ACCC website.

Related Content

• [MINI-PODCAST] Ep 60: Advancing Clinical Trial Equity
• Paving the Way for APPs in Clinical Research [Oncology Issues article]
• How Oncology Advanced Practitioners Can Enhance Community Oncology Research [On-demand webinar]
• Disparities in Cancer Research: A Precursor to Disparate Cancer Outcomes: Health Equities
• Clinical Cancer Advances 2021: ASCO's Report on Progress Against Cancer
• The Multi-Regional Clinical Trials Center of Brigham and Women’s Hospital and Harvard developed a comprehensive guidance document and supplementary toolkit to enhance diversity in clinical trials.
• ACCC Community Oncology Research Institute
• ASCO-ACCC Initiative to Increase Racial and Ethnic Diversity in Clinical Trials
• In Pursuit of Equity: Diversity in Clinical Research Participation [Webinar]
• Practical Solutions to Better Engage Cancer Professionals with Communities of Color [Webinar]

Thank you to Pfizer Oncology for their collaboration and support in hosting the ACCC-Harborside Virtual Summit.